180 related articles for article (PubMed ID: 29134319)
1. Regional levels of physiological α-synuclein are directly associated with Lewy body pathology.
Erskine D; Patterson L; Alexandris A; Hanson PS; McKeith IG; Attems J; Morris CM
Acta Neuropathol; 2018 Jan; 135(1):153-154. PubMed ID: 29134319
[No Abstract] [Full Text] [Related]
2. Regional Overlap of Pathologies in Lewy Body Disorders.
Colom-Cadena M; Grau-Rivera O; Planellas L; Cerquera C; Morenas E; Helgueta S; Muñoz L; Kulisevsky J; Martí MJ; Tolosa E; Clarimon J; Lleó A; Gelpi E
J Neuropathol Exp Neurol; 2017 Mar; 76(3):216-224. PubMed ID: 28395086
[TBL] [Abstract][Full Text] [Related]
3. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Uchihara T; Giasson BI
Acta Neuropathol; 2016 Jan; 131(1):49-73. PubMed ID: 26446103
[TBL] [Abstract][Full Text] [Related]
4. Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathology.
Mastenbroek SE; Vogel JW; Collij LE; Serrano GE; Tremblay C; Young AL; Arce RA; Shill HA; Driver-Dunckley ED; Mehta SH; Belden CM; Atri A; Choudhury P; Barkhof F; Adler CH; Ossenkoppele R; Beach TG; Hansson O
Nat Commun; 2024 Jun; 15(1):5133. PubMed ID: 38879548
[TBL] [Abstract][Full Text] [Related]
5. The genetics of dementia with Lewy bodies: what are we missing?
Meeus B; Theuns J; Van Broeckhoven C
Arch Neurol; 2012 Sep; 69(9):1113-8. PubMed ID: 22635379
[TBL] [Abstract][Full Text] [Related]
6. Abnormal neurites containing C-terminally truncated alpha-synuclein are present in Alzheimer's disease without conventional Lewy body pathology.
Lewis KA; Su Y; Jou O; Ritchie C; Foong C; Hynan LS; White CL; Thomas PJ; Hatanpaa KJ
Am J Pathol; 2010 Dec; 177(6):3037-50. PubMed ID: 21056999
[TBL] [Abstract][Full Text] [Related]
7. α-synuclein phosphorylation and truncation are normal events in the adult human brain.
Muntané G; Ferrer I; Martinez-Vicente M
Neuroscience; 2012 Jan; 200():106-19. PubMed ID: 22079575
[TBL] [Abstract][Full Text] [Related]
8. Neuropathologic analysis of Lewy-related α-synucleinopathy in olfactory mucosa.
Funabe S; Takao M; Saito Y; Hatsuta H; Sugiyama M; Ito S; Kanemaru K; Sawabe M; Arai T; Mochizuki H; Hattori N; Murayama S
Neuropathology; 2013 Feb; 33(1):47-58. PubMed ID: 22672612
[TBL] [Abstract][Full Text] [Related]
9. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
[TBL] [Abstract][Full Text] [Related]
10. Pathological roles of α-synuclein in neurological disorders.
Vekrellis K; Xilouri M; Emmanouilidou E; Rideout HJ; Stefanis L
Lancet Neurol; 2011 Nov; 10(11):1015-25. PubMed ID: 22014436
[TBL] [Abstract][Full Text] [Related]
11. Lewy-like aggregation of α-synuclein reduces protein phosphatase 2A activity in vitro and in vivo.
Wu J; Lou H; Alerte TN; Stachowski EK; Chen J; Singleton AB; Hamilton RL; Perez RG
Neuroscience; 2012 Apr; 207():288-97. PubMed ID: 22326202
[TBL] [Abstract][Full Text] [Related]
12. Non-uniformity in the regional pattern of Lewy pathology in brains of dementia with Lewy bodies.
Yamamoto R; Iseki E; Marui W; Togo T; Katsuse O; Kato M; Isojima D; Akatsu H; Kosaka K; Arai H
Neuropathology; 2005 Sep; 25(3):188-94. PubMed ID: 16193834
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated NUB1 distinguishes α-synuclein in Lewy bodies from that in glial cytoplasmic inclusions in multiple system atrophy.
Tanji K; Miki Y; Mori F; Kon T; Kakita A; Takahashi H; Wakabayashi K
Brain Pathol; 2019 Nov; 29(6):803-812. PubMed ID: 31006160
[TBL] [Abstract][Full Text] [Related]
14. Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging.
Adler CH; Beach TG; Zhang N; Shill HA; Driver-Dunckley E; Caviness JN; Mehta SH; Sabbagh MN; Serrano GE; Sue LI; Belden CM; Powell J; Jacobson SA; Zamrini E; Shprecher D; Davis KJ; Dugger BN; Hentz JG
J Neuropathol Exp Neurol; 2019 Oct; 78(10):891-899. PubMed ID: 31504679
[TBL] [Abstract][Full Text] [Related]
15. Neuropathology of Lewy body disease: Clinicopathological crosstalk between typical and atypical cases.
Kon T; Tomiyama M; Wakabayashi K
Neuropathology; 2020 Feb; 40(1):30-39. PubMed ID: 31498507
[TBL] [Abstract][Full Text] [Related]
16. Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.
Ishizawa T; Mattila P; Davies P; Wang D; Dickson DW
J Neuropathol Exp Neurol; 2003 Apr; 62(4):389-97. PubMed ID: 12722831
[TBL] [Abstract][Full Text] [Related]
17. Fabry Disease With Concomitant Lewy Body Disease.
Del Tredici K; Ludolph AC; Feldengut S; Jacob C; Reichmann H; Bohl JR; Braak H
J Neuropathol Exp Neurol; 2020 Apr; 79(4):378-392. PubMed ID: 32016321
[TBL] [Abstract][Full Text] [Related]
18. Transgenic mice overexpressing tyrosine-to-cysteine mutant human alpha-synuclein: a progressive neurodegenerative model of diffuse Lewy body disease.
Zhou W; Milder JB; Freed CR
J Biol Chem; 2008 Apr; 283(15):9863-70. PubMed ID: 18238775
[TBL] [Abstract][Full Text] [Related]
19. TIGAR inclusion pathology is specific for Lewy body diseases.
López KLR; Simpson JE; Watson LC; Mortiboys H; Hautbergue GM; Bandmann O; Highley JR
Brain Res; 2019 Mar; 1706():218-223. PubMed ID: 30267647
[TBL] [Abstract][Full Text] [Related]
20. Progression and staging of Lewy pathology in brains from patients with dementia with Lewy bodies.
Marui W; Iseki E; Nakai T; Miura S; Kato M; Uéda K; Kosaka K
J Neurol Sci; 2002 Mar; 195(2):153-9. PubMed ID: 11897247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
